Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GPhA Objection To Generic Drug Rule Could Backfire, FDA Counsel Troy Warns

Executive Summary

The generic industry should consider carefully any attempt to derail FDA's regulatory approach to Waxman/Hatch reform, agency Chief Counsel Daniel Troy told the Generic Pharmaceutical Association

You may also be interested in...



Generic 180-Day Exclusivity Forfeiture: What If “Failure” Is Not Your Fault?

A generic drug firm at risk of losing 180-day exclusivity for a product because of FDA's new forfeiture triggers may have some legal remedies beyond those already tried against the agency

Generic 180-Day Exclusivity Forfeiture: What If “Failure” Is Not Your Fault?

A generic drug firm at risk of losing 180-day exclusivity for a product because of FDA's new forfeiture triggers may have some legal remedies beyond those already tried against the agency

Generic Firms Use Pediatric Exclusivity As Weapon In Toprol XL Fight

Sandoz and KV Pharmaceutical are locked in a regulatory struggle to keep each other's generic versions of AstraZeneca's Toprol XL (metoprolol extended release) off the market

Related Content

UsernamePublicRestriction

Register

PS041200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel